A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vz66nj/orally_inhaled) has announced the addition of the "Orally Inhaled ...

The IMPACT and ETHOS trials showed that single-inhaler triple therapy significantly reduce the rate of COPD exacerbation and mortality compared with dual bronchodilators. Findings are from an ...

- Approval of Utibron Neohaler brings an important new dual combination bronchodilator option to patients with chronic obstructive pulmonary disease (COPD) - COPD, a chronic lung disease that makes it ...

(Reuters Health) - People with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and strokes right after they start ...

Delivery of asthma medication with pressurized metered-dose inhalers is economical, effective, and convenient. This method of delivery is a critical part of the medical management program for most ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people ...

In asthma, the combination is indicated for adults and kids ages 6 and older to prevent symptoms (not for acute attacks); in COPD, the inhaler is approved as a maintenance treatment to improve ...

Please provide your email address to receive an email when new articles are posted on . For mild to moderate asthma, many providers reported prescribing a 110 µg/actuation fluticasone metered dose ...

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...